{"id":"W2806800866","doi":"10.1200/jco.2018.36.15_suppl.1031","title":"Serum PD-L1 and outcomes in CCTG MA.31 phase 3 trial of anti-HER2 therapy in first-line HER2+ metastatic breast cancer patients (trastuzumab arm only).","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of British Columbia; Queen's University","funders":"","keywords":"Medicine; Trastuzumab; Internal medicine; Metastatic breast cancer; Oncology; Lapatinib; Taxane; Breast cancer; Univariate analysis; Cancer; Multivariate analysis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002059495,0.0002685775,0.002753068,0.0003178847,0.00003121051,0.000006903432,0.0002050818,0.0002618521,0.0003392941],"category_scores_gemma":[0.001004716,0.000184627,0.0003237586,0.0003046934,0.0005517378,0.0002225874,0.00005325587,0.0008877919,0.000003558504],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003332299,"about_ca_system_score_gemma":0.001516887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002108512,"about_ca_topic_score_gemma":0.001328805,"domain_scores_codex":[0.9951158,0.0004240191,0.003306227,0.0003020117,0.0004696931,0.0003822506],"domain_scores_gemma":[0.9952009,0.001583779,0.002150551,0.000229294,0.0005526165,0.0002829159],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1597124,0.01524041,0.4684873,0.0000407016,0.0004774428,0.0001421049,0.0003490559,0.0000165238,0.00006457217,0.000008115807,0.00007365398,0.3553877],"study_design_scores_gemma":[0.2772631,0.03806294,0.679001,0.000226228,0.0001389684,0.0001208876,0.000114902,0.00004934561,0.00007863614,0.0003808558,0.004433461,0.0001296483],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9891702,0.0004788938,0.00004892523,0.007942063,0.001535191,0.0006721457,0.00006515065,0.000006993041,0.00008045899],"genre_scores_gemma":[0.9938079,0.002154015,0.001223298,0.001727185,0.00095995,0.00001367146,0.00000282376,0.00003371747,0.00007746055],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3552581,"threshold_uncertainty_score":0.7528871,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0924004381767024,"score_gpt":0.4892809865557027,"score_spread":0.3968805483790003,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}